Credit Agricole S A Buys 7,550 Shares of HealthEquity, Inc. $HQY

Key Points

• Credit Agricole S A has increased its stake in HealthEquity, Inc. (NASDAQ: HQY) by 29.1%, bringing its holdings to 33,496 shares valued at approximately $2.96 million.
• In the first quarter, several institutional investors significantly adjusted their positions in HealthEquity, including a 7,983.6% increase by Mirae Asset Global Investments Co. Ltd.
• HealthEquity reported a $0.97 EPS for the quarter, surpassing analysts' expectations, and analysts have a consensus "Buy" rating with an average price target of $118.55.

Credit Agricole S A grew its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 29.1% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 33,496 shares of the company's stock after purchasing an additional 7,550 shares during the period. Credit Agricole S A's holdings in HealthEquity were worth $2,960,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently made changes to their positions in HQY. BI Asset Management Fondsmaeglerselskab A S acquired a new stake in HealthEquity in the first quarter valued at approximately $65,000. Hsbc Holdings PLC boosted its position in HealthEquity by 14.7% in the first quarter. Hsbc Holdings PLC now owns 3,089 shares of the company's stock valued at $273,000 after buying an additional 395 shares in the last quarter. Wellington Management Group LLP boosted its position in HealthEquity by 24.9% in the first quarter. Wellington Management Group LLP now owns 848,940 shares of the company's stock valued at $75,021,000 after buying an additional 169,337 shares in the last quarter. Aviso Financial Inc. acquired a new stake in HealthEquity in the first quarter valued at approximately $158,000. Finally, Versor Investments LP boosted its position in HealthEquity by 235.1% in the first quarter. Versor Investments LP now owns 30,492 shares of the company's stock valued at $2,695,000 after buying an additional 21,392 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, Director Jon Kessler sold 134,183 shares of HealthEquity stock in a transaction on Friday, June 6th. The shares were sold at an average price of $112.08, for a total transaction of $15,039,230.64. Following the completion of the transaction, the director owned 253,510 shares of the company's stock, valued at $28,413,400.80. This trade represents a 34.61% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Michael Henry Fiore sold 1,794 shares of HealthEquity stock in a transaction on Monday, July 7th. The stock was sold at an average price of $101.73, for a total transaction of $182,503.62. Following the transaction, the executive vice president directly owned 53,225 shares of the company's stock, valued at $5,414,579.25. This represents a 3.26% decrease in their position. The disclosure for this sale can be found here. Insiders sold 291,744 shares of company stock valued at $32,705,007 over the last quarter. Insiders own 1.50% of the company's stock.

HealthEquity Trading Down 1.5%

NASDAQ HQY traded down $1.35 during mid-day trading on Wednesday, reaching $87.98. 872,967 shares of the stock were exchanged, compared to its average volume of 1,006,108. HealthEquity, Inc. has a one year low of $73.84 and a one year high of $116.65. The stock has a 50 day simple moving average of $96.29 and a 200-day simple moving average of $96.21. The stock has a market cap of $7.61 billion, a P/E ratio of 64.22, a P/E/G ratio of 1.35 and a beta of 0.54. The company has a debt-to-equity ratio of 0.50, a current ratio of 4.06 and a quick ratio of 4.06.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share for the quarter, topping analysts' consensus estimates of $0.81 by $0.16. HealthEquity had a net margin of 9.80% and a return on equity of 11.01%. The business had revenue of $330.80 million during the quarter, compared to the consensus estimate of $322.25 million. During the same quarter last year, the firm earned $0.80 earnings per share. HealthEquity has set its FY 2026 guidance at 3.610-3.78 EPS. On average, analysts anticipate that HealthEquity, Inc. will post 2.32 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts have weighed in on HQY shares. The Goldman Sachs Group raised their target price on shares of HealthEquity from $94.00 to $104.00 and gave the company a "neutral" rating in a research report on Wednesday, June 4th. Barrington Research lifted their target price on shares of HealthEquity from $112.00 to $125.00 and gave the stock an "outperform" rating in a research report on Thursday, June 5th. Royal Bank Of Canada upped their price target on shares of HealthEquity from $112.00 to $117.00 and gave the company an "outperform" rating in a research report on Wednesday, June 4th. JMP Securities raised their price target on shares of HealthEquity from $110.00 to $117.00 and gave the company a "market outperform" rating in a research note on Wednesday, June 4th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of HealthEquity from $98.00 to $115.00 and gave the stock a "buy" rating in a report on Thursday, June 5th. One equities research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of "Buy" and a consensus target price of $118.55.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.